1. Home
  2. CVEO vs TTRX Comparison

CVEO vs TTRX Comparison

Compare CVEO & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

N/A

Current Price

$36.06

Market Cap

294.1M

ML Signal

N/A

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$9.31

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVEO
TTRX
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
294.1M
298.8M
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
CVEO
TTRX
Price
$36.06
$9.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
★ $44.41
$25.00
AVG Volume (30 Days)
★ 216.7K
83.6K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.90
N/A
Revenue Next Year
$5.02
$900.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.97
$2.57
52 Week High
$38.06
$16.45

Technical Indicators

Market Signals
Indicator
CVEO
TTRX
Relative Strength Index (RSI) 58.84 42.37
Support Level $31.37 $8.75
Resistance Level $38.06 $11.17
Average True Range (ATR) 2.23 0.98
MACD 0.35 0.06
Stochastic Oscillator 73.29 39.55

Price Performance

Historical Comparison
CVEO
TTRX

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: